News & Info


Page 5 of 28« First...34567...1020...Last »

November 21, 2015

Contrast Sensitivity Chart

Posted in: Eye Conditions, Vision Tests

November 21, 2015

Hyperacuity Grid

Posted in: Eye Conditions, Vision Tests

This uses your hyperacuity to easily locate areas of visual distortion possibly caused by fluid or blood leakage in your retina. Print this page, then cut out the strip of dots below. With one eye shut, gaze at the center of the graph from a distance of about 12 inches (30 cm). Slide the strip
read more »

November 16, 2015

X-82 Oral Medication May Reduce Number of Intravitreal Injections for Wet AMD

Posted in: Latest News, Research and Developments

No cure yet exists for wet AMD, but three FDA-approved therapies are slowing the progress of wet AMD and reducing the amount of vision loss. These treatments are ranibizumab (Lucentis), aflibercept (Eylea), and off-label bevacizumab (Avastin). These medications are highly successful, but they must be injected directly into the eye, and the treatment often needs
read more »

November 16, 2015

Iluvien Similar to Anti-VEGF Drugs as Treatment for Diabetic Retinopathy

Posted in: Latest News, Research and Developments, Therapies, Treatments, and Procedures

On February 16, Charles C. Wykoff, MD, PhD, announced to the American Academy of Ophthalmology annual meeting that Iluviuan (fluocinolone acetonide) treatment, after 1.3 injections over 3 years in the FAME trials, “significantly reduced progression to prolific diabetic retinopathy from 31% to 17%, a similar reduction as observed with monthly anti-VEGF treatments.” Iluvian (Alimera Sciences)
read more »

November 16, 2015

Lucentis effective for proliferative diabetic retinopathy

Posted in: Latest News, Therapies, Treatments, and Procedures

NIH-funded clinical trial marks first major advance in therapy in 40 years A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy. The trial, conducted by the Diabetic Retinopathy Clinical Research Network (DRCR.net) compared Lucentis with a type of laser
read more »

November 7, 2015

Medicare Covers Annual Eye Exams for Diabetics

Posted in: Latest News

November is American Diabetes Month. To prevent diabetes-related vision loss, the American Academy of Ophthalmology recommends people with diabetes get a dilated eye exam each year.   One in four Americans age 65 or older has diabetes, putting them at increased risk for vision loss and blindness. Fortunately, diabetes-related vision loss is largely preventable with
read more »

October 31, 2015

LowViz Guide Completes Successful Pilot Program

Posted in: Latest News

New indoor navigation app available free for low vision conventions. LowViz Guide, an indoor navigation app for the visually impaired, was tested this past summer by Macular Degeneration Support (MD Support) at six national and state conventions around the U.S. The purpose of the ambitious pilot project was to test the operation of, and public response
read more »

October 27, 2015

RXI-109 May Reduce Retinal Scarring

Posted in: Latest News, Research and Developments

New drug silences connective tissue growth factor (CTGF), which plays a key role in tissue regeneration and repair. by Dan Roberts One of the most serious causes of vision loss is development of scar tissue on, in, or under the retina. People can develop retinal scarring from severe myopia, ocular histoplasmosis syndrome, and wet age-related
read more »

September 28, 2015

Wet AMD and DME Patients Sought For New Study

Posted in: Latest News

PIVOT Study: Patient-centric Innovative Vision Home Testing Patients are being sought to participate in a unique study to gauge the feasibility of a home-monitoring system. The PIVOT study is a clinical study to determine if patients with diabetic macular edema (DME) or wet age-related macular degeneration (wet AMD) can use a mobile medical application (mVT™) on a smart phone (Apple iPhone®) or
read more »

September 27, 2015

Retinitis Pigmentosa

Posted in: Eye Conditions

by David Twigg (freelance writer, Sheffield, England) (Reprinted here with permission from https://www.edel-optics.co.uk/Retinitis-Pigmentosa.html) Retinitis Pigmentosa covers a group of eye conditions affecting the retina, leading to sight problems and loss of vision. It is one of the conditions falling under the heading of Rod-Cone Dystrophy, genetic conditions in which the rod and cone cells in the eye deteriorate
read more »

September 16, 2015

Diet, exercise, smoking habits, and genes interact to affect AMD risk

Posted in: Latest News, Research and Developments

NIH-funded study points to converging factors that drive disease-related inflammation People with a genetic predisposition for age-related macular degeneration (AMD) significantly increased their odds of developing the blinding eye disorder if they had a history of heavy smoking and consistently did not exercise or eat enough fruits and vegetables, according to an observational study of
read more »

September 16, 2015

New App for AMD Patients

Posted in: Latest News

  Prevent Blindness, the nation’s oldest volunteer eye health and safety organization, has launched a new resource, “GuideMe,” designed for those who have been diagnosed with Age-related Macular Degeneration (AMD). AMD affects more than 2 million Americans ages 50 and older.  And, according to the recent Prevent Blindness “Future of Vision: Forecasting the Prevalence and
read more »

September 8, 2015

Ocata’s Stem Cell Trials Entering Phase 2

Posted in: Latest News, Research and Developments

Results from First Cohort Expected in the Second Quarter of 2016 Acucela (formerly Ocata) has announced that the first patient has been enrolled in the company’s Phase 2 clinical trial using Ocata’s proprietary RPE cells in patients with atrophic (dry) age-related macular degeneration (AMD). The purpose of the trial is to evaluate safety and explore efficacy as compared
read more »

September 4, 2015

Long-term Treatment for Wet AMD Enters Phase 2 Trials

Posted in: Latest News, Research and Developments

Neurotech Pharmaceuticals, Inc. has announced that they have enrolled the first patient in their multicenter Phase 2 clinical trial of NT-503 Encapsulated Cell Therapy (ECT) for the long-term treatment of wet macular degeneration (AMD). NT-503 is a unique vascular endothelial growth factor (VEGF) receptor protein continuously produced by Neurotech’s versatile ECT implant. “This landmark proof-of-concept
read more »

August 26, 2015

New Book On Eye Nutrition Answers Common Questions

Posted in: Latest News

Leading nutrition expert Jeffrey Anshel, OD, FAAO, has just published a new book titled “What You Must Know about Food and Supplements for Optimal Vision Care.” It is a practical guide to diets, supplements and lifestyles for peak ocular health, with excellent information about how to integrate supplements with mainstream medical treatments whenever appropriate. Dr.
read more »

Page 5 of 28« First...34567...1020...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann